DNAprint Genomics (DNAG)

[Gcbr]

Sure makes you wonder.

http://www.cancerfacts.com/Home_News.asp?NewsId=1951&CB=14&CancerTypeId=4

I like this part best.

The FDA approval covers those patients with particular genetic mutation on one chromosome that results in the inability of the bone marrow to produce enough normal red blood cells and blood-clotting platelets. Patients with this type of MDS require periodic blood and platelet transfusions and treatment with antibiotics for infections to remain well.

Take Care
Arch